Healthcare Workers (HCWs) are constantly at risk of exposure to viral infections such as hepatitis B virus (HBV), human immune deficiency virus (HIV) and hepatitis C virus (HCV). We aim at demonstrating the results of a three-year period of a surveillance program in Iran with the prospective follow-up of HCWs exposed to blood-borne viruses. HCWs who had experienced an occupational exposure to HBV, HCV or HIV from September 2005 to 2008 were enrolled in the study. Age, gender, route of exposure, type of fluid, type of virus, job, department, working shift, work experience, wearing gloves when exposed, history of HBV vaccination and the serum level of anti HBs antibody were recorded for all participants through an individual interview. Serum samples were taken from both HCWs and the sources of exposure and were tested by enzyme linked immunosorbent assay (ELISA). The data were gathered through questionnaires completed by a nurse under the supervision of a specialist of infectious diseases. In this study, 100 HCWs who were occupationally exposed to HIV, HCV or HBV were included. Most exposures had occurred among nurses (35%), followed by residents (29%), interns (18%), housekeepers (7%), the lab staff (6%), and specialists (5%). Most of the exposures had occurred in emergency (21%) and surgical (20%) wards. The most common route of exposure was percutaneous injuries (77%) and the most common cases had contacted with needles and angiocaths (71.1%) during injection or opening vein routes (21%). Establishing a surveillance system for registering the occurrence of occupational hazardous exposures, performing prophylactic measures and following up the exposed is a necessity in hospitals so that the number of exposures and occupational diseases among the HCWs can be decreased.
Introduction
Healthcare Workers (HCWs) are constantly at risk of exposure to viral infections such as hepatitis B virus (HBV), human immune deficiency virus (HIV) and hepatitis C virus (HCV) through percutaneous, mucosal and non-intact skin having contact with blood and other body fluids that are potentially infectious. Hepatitis B is a known occupational hazard for the HCWs [1] . Following occupational contacts of unvaccinated staff with the contaminated blood of an HBsAg positive patient; they should be followed by prophylactic measures including HBIG with vaccine. The efficacy of this method has been reported to be 85% -95% in children born to HBsAg positive mothers, but it had not been sufficiently investigated in relation to HCWs [2, 3] . Although, hepatitis B can be highly prevented through timely vaccinations, vaccination and check up for the antibody thereafter are not yet taken seriously by some HCWs.
Another occupational infection for HCWs is HIV with the risk of transferring through a needle stick and mucosal surfaces at 0.3% and 0.09%, respectively. Following the contact with the infected blood, administering antiretroviral drugs such as Zidovudine plus Lamivudine with or without Nelfinavir within the first 4 hours, would be effective in preventing the infection in 81% of the cases [3] . These drugs are expensive and there may be the risk of creating resistant strains, so they should be cautiously used by consulting with a specialist of infectious diseases.
Hepatitis C is another blood borne infection that unfortunately has no appropriate immunoglubolin or vaccination. The prevalence of hepatitis C is 0.3% in Iran and the risk of infection through a needle stick is 1% -8% [1] .
We aim at demonstrating the results of a three-year period of a surveillance program in Iran with the prospective follow-up of HCWs exposed to blood-borne viruses.
Materials & Methods
Since the year 2005, a surveillance system has been established in HIV/AIDS Counseling center in Tehran University of Medical Sciences through which health care workers (HCWs) can report needle-stick injuries not only with HIV but also with HBV and HCV; they can ask for consultations on follow-up, as well. This study was designed to assess the profile of these clients regarding the setting in which exposures had occurred, the HBV vaccination status and the efficacy of the post-exposure prophylaxis for HIV and HBV. HCWs that had experienced an occupational exposure to HBV, HCV or HIV from September 2005 to 2008 were enrolled in the study. By HCWs, we mean physicians, medical students, nurses, the laboratory staff and housekeepers. Exposure refers to percutaneous injuries caused by needle stick and other sharp instruments and tools as well as contacts through mucosal surfaces and damaged skin (dermatitis or wound). Contaminants include blood, bloody secretions, CSF, pleural, peritoneal, synovial and pericardial fluids.
Pregnant women, people with chronic renal and hepatic diseases, immune deficiency syndromes and previous infections with these viruses on the basis of lab evidence were excluded.
Age, gender, route of exposure, type of fluid, type of virus, job, department, working shift, work experience, wearing gloves when exposed, history of HBV vaccinetion and the serum level of anti HBs antibody were recorded for all participants through an individual interview. If a HCW was unaware of the HBsAb level, it was tested.
Post-exposure measures: Serum samples were taken from both HCWs and the sources of exposure and were tested by enzyme linked immunosorbent assay (ELISA) to detect HBsAg, HBsAb, HCVAb, and HIVAb. In source of positive serology of HIV, the samples were tested using ELISA two times and the samples positive for HIVAb ELISA were retested by Western Blot as a complementary test. The samples found positive with both ELISA and Western Blot HIVAb were considered to be infected by HIV. In cases of exposure to HBV with no previous vaccination or negative antibody despite previous vaccinations, HBIG and HBV intra-muscular vaccination in months 0, 3 and 6 were administered and one month later (month 7), HBsAg and HBsAb titers were checked [2, 3] .
In case of HCV exposure, the ELISA Anti HCV Ab and liver function enzymes were checked 3 times (0, 3 and 6 months after the exposure).
When there was an exposure to HIV, depending on the severity of the exposure (solid needle, being superficial or being infected by patients with an HIV viral load <1500 copies/ml to high risk injuries such as those resulting from hollow bore needles, presence of visible blood on the device, or exposure from a needle that was in an artery or vein of the source), two different protocols were used for 4 weeks prophylaxis: Zidovudine [ZDV] (600 mg/d) + Lamivudine [3TC] (150 mg/bd) for mild exposures and ZDV + 3TC + Nelfinavir (750 mg/tds) for severe exposures. During the follow-up period, the cases received some information on the effects of the drugs and were advised to apply preventive measures including condom use. HIVAb was checked 3 times during the follow-up period (6, 12 and 24 weeks after the exposure considering the window period) [3] .
The efficacy of postexposure prophylaxis was considered as the main outcome of the study. It is defined as the rate or percentage of the decrease in the probability of HIV infection after prophylaxis (PEP). HIV seroconversion refers to the negative serum sample for HIVAb until one month after the exposure and its becoming positive during a six-month period after the exposure [4] .
The data were gathered through questionnaires completed by a nurse under the supervision of a specialist of infectious diseases; the data were then analyzed using SPSS ver. 11.5. The mean and standard deviation were calculated for quantitative variables, and absolute and relative frequencies of categorical variables were computed for presenting the results.
Written informed consent was obtained from patients. The study was approved by the Ethics Committee of Tehran University of Medical Sciences.
Results
In this study, 100 HCWs who were occupationally exposed to HIV, HCV or HBV were included (Figure 1) . The mean age of the exposed HCWs was 30.46 ± 7.1 (SD) years (range 20 -56) and 54% of them were female. Most exposures had occurred among nurses (35%), followed by residents (29%), interns (18%), housekeepers (7%), the lab staff (6%), and specialists (5%). Excluding the HCWs in training (residents and interns) the mean of the employment period was 6.5 ± 6 years; 75% had less than 5 years, 9% between 5 and 10 years and 16% had over 10 years of experience. Table 1 shows exposure-related features. Most of the exposures had occurred in emergency (21%) and surgical (20%) wards. The most common route of exposure was percutaneous injuries (77%) and the most common cases were having contact with needles and angiocaths (71.1%) during injection or opening vein routes (21%). The most common contaminant was blood (84%). Most of the exposures had occurred during the morning work shifts (54%) and then, the night shifts (25%). Only 69% of the exposed HCWs were using gloves at the time of their exposure.
The most common exposures among these personnel were to HIV (58 cases), followed by HCV (53 cases) and then HBV (31 cases). In 36 cases of exposure, the source was contaminated with more than one kind of virus; Figure 1 shows the prevalence of co-infection patterns among the source patients. Exposure-related features are also outlined by the type of viruses in Table 2 .
Ninety percent of the exposed HCWs (n = 90) had received at least one dose of HBV vaccine before their recent exposure; 5.5% of them had taken one dose (n = 5), 8.8% two doses (n = 8) and 88.5% three doses of the vaccine. Based on personal declaration, the HBsAb was positive in 35% of the cases at the time of exposure, 9% had negative HBsAb and 56% did not know the status of their HBsAb.
Among 31 HCWs who had exposure to HBV, twenty HCWs (64.5%) had negative serology against HBV at the time of exposure ( Table 3) . No cases of seroconversion were observed among the 20 HCWs exposed to HBV who had received prophylaxis (HBIG + vaccination); the level of antibody against HBV had risen in all of them seven months later.
There were 9 cases exposed to viruses other than HBV but they were found to be HBsAb negative; these sub- jects were given vaccinations. No cases of seroconversion were observed among the HCWs exposed to HCV.
In 18 cases out of 58 exposures to HIV, the two-drug protocol (ZDV + 3TC) was used and in 40 cases, ZDV + 3TC + Nelfinavir was given based on the characteristics of exposure and the source patients. No case of seroconversion was seen among the study group during the six-month follow-up period. around the world experience exposures to sharp and cutting tools which result in 1600 cases of infection with HCV, 66,000 HBV infections and 1000 HIV infections. Damages caused by sharp tools are the main source of HCV infections in the way that it accounts for 40% of all cases of HCV among the HCWs. In addition, 4.4% of HIV and 37% of HBV infections among the HCWs are due to the damages caused by sharp tools in occupational exposures [5] . In the present study, 100 cases of occupational exposures were included. In 36 cases of the mentioned 100 subjects, the source was contaminated by more than one virus. Totally, 58, 31 and 53 cases of exposures to HIV, HBV and HCV had occurred. In this study, the highest rate of exposure (around 35%) was seen among the nurses. A study carried out on 900 HCWs in three hospitals of Tehran in 2005, reported that 26.1% of the exposed cases were nurses [6] . Other studies in Taiwan and Saudi Arabia have also showed the highest rates of exposure among the nurses (60.6% and 56.8%, respectively) [7, 8] . Since nurses have more frequent contacts with patients, it is not surprising to see the highest rate of exposure among them.
In our study, the most common places of exposure were emergency (21%) and surgical (20%) wards. In a study from Saudi Arabia, 42.5% of the exposures were seen in clinical departments and 19.2% of them were in emergency departments [8] . Another study in Tehran showed the department of internal medicine was the most common place of exposure (23.3%) [6] . This difference may be due to different clinical procedures being performed in different medical systems and also the type of instruments used. In an emergency setting, less attention is paid to cautionary measures like wearing gloves while taking blood samples or performing invasive diagnostic-therapeutic procedures because of the haste involved, it should be expected to see more cases of exposure in these departments.
In terms of work experience, in the present study, 75% of the exposures had occurred among the HCWs with less than 5 years of work experience; in other words, less experience means more chance of being exposed. This finding is similar to the results of the studies conducted in Turkey and Saudi Arabia [9, 10] . This may be due to the fact that more experience causes people to become more cautious when performing potentially dangerous tasks. Most exposures had occurred during the first two years, because of their inexperience or high workload.
The most common route of exposure in our study was percutaneous exposure (77%); mostly due to the insertion of the needle stick when taking blood samples or performing similar procedures. Similar results have been found in other studies [8, 11, 12] .
In this study, 31% of the exposed cases had not worn gloves when they got exposed. In another study, this figure was 38.2% and in a study in Turkey, it was 28% [7, 13] . Knowing that the most common place of exposure was the emergency department, the reason for not wearing gloves might have been haste or the high load of patients to be worked on, which possibly resulted in the temporary shortage of gloves.
In our study, 88.5% of the HCWs were fully vaccinated (3 doses) while in Egypt, the figure was only 15.8% [12] . In recent years, the coverage of immunization against HBV has improved due to the existence of more active infection control committees in hospitals, educational programs held for the HCWs in this regard and more cooperative behaviors of hospital authorities. However, only 44% of the HCWs of our study knew about their HBsAb serostatus at the time of exposure and were aware of the necessity of being checked for HBsAb after vaccinations.
The main objective of our study was assessing post exposure prophylaxis with antiretroviral drugs in cases exposed to HIV and also vaccination plus HBIG for HBV and their follow up. As for the efficacy of hepatitis B vaccine in occupational exposures, unlike the prevention of fetal infections with HBV, there have been few studies, but the mentioned figure is 90% [1] . In our study, no cases of positive HBsAg were seen after the prophylaxis. However, our sample size (n = 20) was small and we need to assess the efficacy with a larger sample.
In 2002, the numbers of proven and probable cases of HIV following occupational exposures were respectively 106 and 238 throughout the world, and also 26 cases of infection with HIV despite prophylaxis were reported [14] . In 1996, it was suggested that using zidovudine for cases of occupational exposure to HIV may decrease the hazard, and using a combination therapy was also recommended [15] . No certainly successful method for prophylaxis is available and still preventing contacts with blood is the primary method of prevention. HIV can be communicated despite prophylaxis and there have been reports of incomplete combination therapy for preventing its communication among HCWs [15, 16] . Some studies have shown that 2-drug and 3-drug therapies were efficacious in 79% and 83% of the cases, respectively. These figures indicate that 2-drug therapy lowers the risk of infection to 0.06% and 3-drug therapy reduces the risk to 0.05%. No information is available regarding the comparisons between 2-and 3-drug therapies [4] .
In a case-control study (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) conducted on 665 HCWs who were exposed to these infections without seroconversion, and also the study carried out on 33 HIV patients to determine the risk factors of HIV infection, it was shown that using zidovudine decreased the risk of communication in 81% of the cases (95% CI 48% -94%) [17] . No information is available on the relevant clinical trials. Considering the low risk of communication following the exposure, we may need thousands of HCWs exposed to this virus in order to assess the efficacy of prophylactic measures [18] .
In a study conducted on HCWs exposed to HIV from 1996 to 1998 who had received a prophylactic treatment, no cases of seroconversion were seen among the 306 HCWs who were followed-up for 6 months thereafter [19] . In the study carried out on 380 cases of occupational exposure including 23 cases of HBV, 15 cases of HIV and 12 cases of HCV in India, no cases of infection with these viruses were reported among the exposed HCWs [20] . In our study, no cases of positive HIV were seen. Although this may be due to the prophylaxis, this finding should be considered conservative because of the small sample size of the study.
Hence, considering the fact that according to other studies, there may be a risk of virus communication despite the prophylaxis, it should be recommended that the HCWs observe the principles of occupational safety as the best way of preventing blood borne diseases in dealing with the patients. On the other hand, the vaccination of the HCWs and performing subsequent serological tests to ensure its effect is one of the mainstays of the preventive measures against HBV. On the other hand, establishing a surveillance system for registering the occurrence of occupational hazardous exposures, performing prophylactic measures and following up the exposed is a necessity in hospitals so that the number of exposures and occupational diseases among the HCWs can be decreased.
Limitations & Suggestions
Considering the low transmission risk of the viruses following occupational exposure and the small sample size, not observing seroconversion in the personnel studied in our study cannot necessarily be considered as prophylaxis success.
The authors of the article suggest that in order to evaluate the effectiveness of prophylaxis, occupational exposure cases is conducted with a larger sample size in those undergoing prophylaxis or cases who do not receive it regardless of the reason.
